EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Trending
-
Year-end considerations FY 2024-25: Navigating the evolving accounting landscape
21 Apr 2025 Financial accounting advisory services -
Strategizing year-end closure for FY 2025 and beyond: A guide for financial services
21 Apr 2025 Financial accounting advisory services -
Optimizing EPC logistics: Containerized vs. break-bulk cargo selection
16 Apr 2025 Supply-chain
Select your location
Local sites
Health
We don’t just want to reimagine the health sector — we want to help rebuild it.
Around the world, the health sector is being reimagined in the face of aging populations, increased prevalence of chronic diseases, growth in emerging markets and shifting reimbursement models. Health care organizations must address these challenges while mastering the digital innovation that offers both opportunities and threats. Technology empowers patients, real-time analytics improves care and enables a mind shift toward prevention — but also opens the door to new nontraditional competitors.
At EY, we work with you to reposition and optimize your business models, people strategies and operational structures to address cost pressures, while leveraging the potential of analytics and technologies to improve quality of care.
In this way, we help health organizations stay competitive and deliver better patient outcomes.
Our latest thinking
Can AI drive scalable innovation in life sciences?
AI in life sciences is revolutionizing healthcare with advancements in R&D, personalized medicine, MedTech innovations, and strategies for sustainable AI adoption. Learn more.
17 Mar 2025
Suresh Subramanian
How much productivity can GenAI unlock in India? The AIdea of India 2025
Explore AIdea of India 2025 to find out how Generative AI is revolutionizing industries and productivity in India's digital transformation journey. Stay future-ready with EY India.
14 Jan 2025
Mahesh Makhija
AIdea 2025 report - Industries in transformation: Healthcare
Explore how GenAI is transforming healthcare in India and the impact on patient care, diagnostics, and telemedicine. Learn about the expected 30%-32% productivity boost by 2030.
14 Jan 2025
Kaivaan Movdawalla
What will it take for India to become a global pharma powerhouse by 2047?
Unveiling India's roadmap to a $450 billion pharma industry by 2047 with digital transformation, AI-driven innovation, and strategic industry collaboration.
11 Dec 2024
Suresh Subramanian
India’s MedTech transformation: paving the path to global leadership
India's MedTech industry is undergoing a revolution. Explore the latest trends, government support, and the potential for global dominance. Learn more.
26 Nov 2024
Suresh Subramanian
Confronting India’s cancer crisis: The urgent need for affordable care
India battles rising cancer rates. Learn about challenges, prevention, early detection, and affordable treatment options. Know more.
05 Nov 2024
Srimayee Chakraborty
Transforming healthcare in India with Generative AI
Leverage GenAI in Indian healthcare: a collaborative strategy for high-quality, accessible care, balancing potential with mindful tech integration. Learn more.
30 Aug 2024
Kaivaan Movdawalla
Driving Competitive Differentiation: M&A Outlook for 2023 in Tech Services
Explore Indias healthcare evolution and future goals in our in-depth analysis. Uncover the strides and vision for a healthier India. Learn more.
25 Jun 2024
EY India
How sustainable practices ensure a green healthcare ecosystem
Discover how sustainability and climate change, two major megatrends, are profoundly impacting the entire healthcare ecosystem and its stakeholders. Learn more about green hospitals.
08 Mar 2024
Nitesh Mehrotra
How EY can help
-
Our Smart Health solutions can help your business become a smart health organization. Learn more.
Read more -
The EY R&D Workbench for Pharma is a unique, customized End-to-End ERP solution. It integrates modules covering the entire pharmaceutical R&D and manufacturing lifecycle, including portfolio management, new product development, clinical development, launch, and regulatory management across multiple dosage forms, APIs, and biosimilars. Organizations can benefit from improved market speed, transparency, and accountability across departments.
Read more -
We help health organizations stay competitive and deliver better patient outcomes both now and in the future.
Read more -
EY-Parthenon Health and Wellness Strategy Consulting teams help develop and deliver growth, transaction, digital and value creation strategies. We help health and life sciences organizations build greater financial and operational resilience and technical agility, supporting their future growth within an ever-changing landscape.
Read more
Meet our Healthcare consulting team
Direct to your inbox
Stay up to date with our Editor's picks newsletter.